Please login to the form below

Not currently logged in
Email:
Password:

Avril Lee joins Burson-Marsteller in global role

Based in the UK, she joins the firm as its deputy global healthcare practice chair

Avril LeeBurson-Marsteller (BM) has strengthened its healthcare capabilities with the addition of Avril Lee, who joins the global PR and coms agency as  deputy global healthcare practice chair.

Based in the UK, Lee - who moves to the firm on February 19 - will partner with global healthcare practice chair Helene Ellison to expand the firm’s healthcare representation.

Commenting on the new appointment, BM’s worldwide chair and chief executive officer Don Baer said: “Avril is going to make a big contribution to helping us serve the most important healthcare clients in key markets around the world.”

For the past two years Lee has been serving as managing director of MSLGroup’s UK and EMEA Health Practices, overseeing business that included portfolio communications for Allergan.

Prior to that, she spent two years with Luther Pendragon as a director leading the AbbVie Humira business, and serving on the agency's senior leadership team, and before that she spent a decade with Ketchum London.

Lee said: “I am excited to get started expanding Burson-Marsteller’s healthcare expertise around the globe.”

12th February 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....